Dr. Viralkumar K. Bhanderi, MD

Dr. Bhanderi practices at HCA Florida Capital Hospital in Tallahassee, Florida, part of HCA Healthcare.

Dr. Bhanderi's NPI, 1265518377, was assigned on October 31, 2006. Dr. Bhanderi graduated from LSU Health Shreveport School of Medicine in 2002. Dr. Bhanderi holds Florida license ME101928.

Dr. Bhanderi's primary practice is HCA Florida Capital Hospital, at 2626 Capital Medical Blvd, Tallahassee, FL 32308 in Leon County. The practice phone is (850) 656-5000.

Dr. Bhanderi's primary practice is HCA Florida Capital Hospital in Tallahassee, Florida, part of HCA Healthcare. Dr. Bhanderi is also affiliated with Tallahassee Memorial Hospital. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Bhanderi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhanderi practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Bhanderi's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Bhanderi is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Bhanderi's licenses on file in 2 states: Florida and Georgia.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, immune deficiency disease, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Bhanderi treats.

CMS data shows 26,226 Medicare services from Dr. Bhanderi across 29 procedure codes in 2024, for 341 Medicare patients. Medicare paid $196,496 for them. Every service was in an office.

CMS counts 341 Medicare patients who saw Dr. Bhanderi in 2024. The largest group is 75 to 84, with 134 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhanderi's median patient age at 66, with 66% women.

In 2024, Dr. Bhanderi wrote 1,668 Medicare Part D claims for 253 patients. 71% of them were for generic drugs. CMS names the drug for 1,222 of them, across 39 drugs with 11 or more claims each, at $3,648,874 in total drug cost. In 2023, CMS named 890 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Bhanderi for performance year 2024, reported as part of a group. Dr. Bhanderi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Bhanderi, published from 2020 to 2024. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols. Dr. Bhanderi's most frequent co-authors are Jesus G. Berdeja, MD, David Berz, MD, MPH, PhD and Bo Chao, MD.

Dmand AI links Dr. Bhanderi to 12 clinical trials, 4 of them phase 2 studies. 6 are still active or recruiting. Conditions studied include Breast Neoplasms, Carcinoma, Non-Small-Cell Lung and Rectal Diseases. Arcus Biosciences, Inc. sponsors the most, 2.

CMS Open Payments shows 696 general payments to Dr. Bhanderi from 73 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Amgen Inc. paid the most, $1,027. It also lists 19 research payments totaling $9,840 from 2018 to 2022.

Dmand AI lists 1 award for Dr. Bhanderi, most recently CMS Stage 1 EHR in 2014.

Dr. Bhanderi graduated from LSU Health Shreveport School of Medicine in 2002.

Dr. Bhanderi is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.